PMID,Characteristic/Risk Factor,Exposure,Outcomes,Statistic,Value,Unit,Variability Statistic,Variability Value,Interval Type,Interval Low Bound,Intervale High Bound,p-Value
15930210,NA,Dopamine,Failure (nonresponders),Frequency,1,Number,%,3.7,NA,NA,NA,NA
15930210,NA,Dopamine,Success T1,Frequency,6,Number,%,22.2,NA,NA,NA,NA
15930210,NA,Dopamine,Success T2,Frequency,9,Number,%,33.3,NA,NA,NA,NA
15930210,NA,Dopamine,Success T3,Frequency,7,Number,%,25.9,NA,NA,NA,NA
15930210,NA,Dopamine,Success T4,Frequency,4,Number,%,14.8,NA,NA,NA,NA
15930210,NA,Dopamine,Delayed Failure,Frequency,8,Number,%,29.6,NA,NA,NA,NA
15930210,NA,Dopamine,Total Treatment Failure,Frequency,9,Number,%,33.3,NA,NA,NA,NA
15930210,NA,Epinephrine,Failure (nonresponders),Frequency,2,Number,%,6.3,NA,NA,NA,NA
15930210,NA,Epinephrine,Success T1,Frequency,6,Number,%,18.8,NA,NA,NA,NA
15930210,NA,Epinephrine,Success T2,Frequency,9,Number,%,28.1,NA,NA,NA,NA
15930210,NA,Epinephrine,Success T3,Frequency,6,Number,%,18.8,NA,NA,NA,NA
15930210,NA,Epinephrine,Success T4,Frequency,9,Number,%,28.1,NA,NA,NA,NA
15930210,NA,Epinephrine,Delayed Failure,Frequency,10,Number,%,31.2,NA,NA,NA,NA
15930210,NA,Epinephrine,Total Treatment Failure,Frequency,12,Number,%,37.5,NA,NA,NA,NA
15930210,NA,Dopamine,MBP at Baseline,Mean,25,mm Hg,SD,3,NA,NA,NA,NA
15930210,NA,Epinephrine,MBP at Baseline,Mean,26,mm Hg,SD,3,NA,NA,NA,NA
15930210,NA,Dopamine,Heart Rate at Baseline,Mean,141,Beats per min,SD,12,NA,NA,NA,NA
15930210,NA,Epinephrine,Heart Rate at Baseline,Mean,141,Beats per min,SD,14,NA,NA,NA,NA
15930210,NA,Dopamine,Change in CBV at Baseline,Mean,0,mL/100g,SD,0,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in CBV at Baseline,Mean,0,mL/100g,SD,0,NA,NA,NA,NA
15930210,NA,Dopamine,Change in HbD at Baseline,Mean,0,micro-mol/L,SD,0,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in HbD at Baseline,Mean,0,micro-mol/L,SD,0,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PCO2 at Baseline,Mean,45,mm Hg,SD,6,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2 at Baseline,Mean,48,mm Hg,SD,8,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PO2 at Baseline,Mean,73,mm Hg,SD,22,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2 at Baseline,Mean,70,mm Hg,SD,18,NA,NA,NA,NA
15930210,NA,Dopamine,MBP at T1,Mean,30,mm Hg,SD,7,NA,NA,NA,NA
15930210,NA,Epinephrine,MBP at T1,Mean,29,mm Hg,SD,6,NA,NA,NA,NA
15930210,NA,Dopamine,Heart Rate at T1,Mean,149,Beats per min,SD,17,NA,NA,NA,NA
15930210,NA,Epinephrine,Heart Rate at T1,Mean,153,Beats per min,SD,19,NA,NA,NA,NA
15930210,NA,Dopamine,Change in CBV at T1,Mean,0.27,mL/100g,SD,0.4,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in CBV at T1,Mean,0.17,mL/100g,SD,0.68,NA,NA,NA,NA
15930210,NA,Dopamine,Change in HbD at T1,Mean,3.51,micro-mol/L,SD,13.9,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in HbD at T1,Mean,1.82,micro-mol/L,SD,8.4,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PCO2 at T1,Mean,45,mm Hg,SD,7,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2 at T1,Mean,49,mm Hg,SD,8,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PO2 at T1,Mean,77,mm Hg,SD,22,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2 at T1,Mean,77,mm Hg,SD,16,NA,NA,NA,NA
15930210,NA,Dopamine,MBP at BM,Mean,39,mm Hg,SD,6,NA,NA,NA,NA
15930210,NA,Epinephrine,MBP,Mean,36,mm Hg,SD,4,NA,NA,NA,NA
15930210,NA,Dopamine,Heart Rate,Mean,157,Beats per min,SD,19,NA,NA,NA,NA
15930210,NA,Epinephrine,Heart Rate,Mean,169,Beats per min,SD,19,NA,NA,NA,NA
15930210,NA,Dopamine,Change in CBV,Mean,0.36,mL/100g,SD,0.5,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in CBV,Mean,0.39,mL/100g,SD,0.91,NA,NA,NA,NA
15930210,NA,Dopamine,Change in HbD,Mean,7.99,micro-mol/L,SD,15.4,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in HbD,Mean,4.52,micro-mol/L,SD,10.3,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PCO2,Mean,46,mm Hg,SD,7,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2,Mean,48,mm Hg,SD,8,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PO2,Mean,77,mm Hg,SD,16,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2,Mean,77,mm Hg,SD,17,NA,NA,NA,NA
15930210,NA,Dopamine,MBP,Mean,37,mm Hg,SD,5,NA,NA,NA,NA
15930210,NA,Epinephrine,MBP,Mean,36,mm Hg,SD,5,NA,NA,NA,<0.001
15930210,NA,Dopamine,Heart Rate,Mean,162,Beats per min,SD,17,NA,NA,NA,NA
15930210,NA,Epinephrine,Heart Rate,Mean,174,Beats per min,SD,16,NA,NA,NA,<0.001
15930210,NA,Dopamine,Change in CBV,Mean,0.51,mL/100g,SD,0.61,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in CBV,Mean,0.79,mL/100g,SD,1.13,NA,NA,NA,<0.001
15930210,NA,Dopamine,Change in HbD,Mean,8.46,micro-mol/L,SD,15.6,NA,NA,NA,NA
15930210,NA,Epinephrine,Change in HbD,Mean,8.05,micro-mol/L,SD,8.1,NA,NA,NA,<0.001
15930210,NA,Dopamine,Transcutaneous PCO2,Mean,46,mm Hg,SD,7,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2,Mean,48,mm Hg,SD,10,NA,NA,NA,NA
15930210,NA,Dopamine,Transcutaneous PO2,Mean,75,mm Hg,SD,17,NA,NA,NA,NA
15930210,NA,Epinephrine,Transcutaneous PCO2,Mean,77,mm Hg,SD,20,NA,NA,NA,NA
15930210,NA,Dopamine,PaO2 at Baseline,Mean,69,mm Hg,SD,29,NA,NA,NA,NA
15930210,NA,Dopamine,PaCO2 at Baseline,Mean,42,mm Hg,SD,8,NA,NA,NA,NA
15930210,NA,Dopamine,pH at Baseline,Mean,7.34,Number,SD,7.00E-02,NA,NA,NA,NA
15930210,NA,Dopamine,Base Exess at Baseline,Mean,-3.4,Number,SD,3.2,NA,NA,NA,NA
15930210,NA,Dopamine,Lactate at Baseline,Mean,4.5,mmol/L,SD,4.3,NA,NA,NA,NA
15930210,NA,Dopamine,Glucose at Baseline,Mean,106,mg/dL,SD,67,NA,NA,NA,NA
15930210,NA,Dopamine,Hematocrit at Baseline,Mean,42,%,SD,6,NA,NA,NA,NA
15930210,NA,Dopamine,SCVO2 at Baseline,Mean,67,%,SD,11,NA,NA,NA,NA
15930210,NA,Epinephrine,PaO2 at Baseline,Mean,67,mm Hg,SD,21,NA,NA,NA,NA
15930210,NA,Epinephrine,PaCO2 at Baseline,Mean,44,mm Hg,SD,8,NA,NA,NA,NA
15930210,NA,Epinephrine,pH at Baseline,Mean,4.32,Number,SD,7.00E-02,NA,NA,NA,NA
15930210,NA,Epinephrine,Base Exess at Baseline,Mean,-3.9,Number,SD,4.2,NA,NA,NA,NA
15930210,NA,Epinephrine,Lactate at Baseline,Mean,3.4,mmol/L,SD,2.5,NA,NA,NA,NA
15930210,NA,Epinephrine,Glucose at Baseline,Mean,86,mg/dL,SD,37,NA,NA,NA,NA
15930210,NA,Epinephrine,Hematocrit at Baseline,Mean,41,%,SD,7,NA,NA,NA,NA
15930210,NA,Epinephrine,SCVO2 at Baseline,Mean,70,%,SD,12,NA,NA,NA,NA
15930210,NA,Dopamine,PaO2,Mean,64,mm Hg,SD,14,NA,NA,NA,NA
15930210,NA,Dopamine,PaCO2,Mean,44,mm Hg,SD,6,NA,NA,NA,NA
15930210,NA,Dopamine,pH,Mean,7.33,Number,SD,0.05,NA,NA,NA,NA
15930210,NA,Dopamine,Base Exess,Mean,-3.2,Number,SD,2.9,NA,NA,NA,NA
15930210,NA,Dopamine,Lactate,Mean,3.3,mmol/L,SD,2.3,NA,NA,NA,NA
15930210,NA,Dopamine,Glucose,Mean,140,mg/dL,SD,77,NA,NA,NA,NA
15930210,NA,Dopamine,Hematocrit,Mean,44,%,SD,7,NA,NA,NA,NA
15930210,NA,Dopamine,SCVO2,Mean,71,%,SD,13,NA,NA,NA,NA
15930210,NA,Epinephrine,PaO2,Mean,67,mm Hg,SD,13,NA,NA,NA,NA
15930210,NA,Epinephrine,PaCO2,Mean,42,mm Hg,SD,7,NA,NA,NA,NA
15930210,NA,Epinephrine,pH,Mean,7.3,Number,SD,0.06,NA,NA,NA,NA
15930210,NA,Epinephrine,Base Exess,Mean,-5.4,Number,SD,3.5,NA,NA,NA,NA
15930210,NA,Epinephrine,Lactate,Mean,5.2,mmol/L,SD,2.7,NA,NA,NA,NA
15930210,NA,Epinephrine,Glucose,Mean,192,mg/dL,SD,69,NA,NA,NA,NA
15930210,NA,Epinephrine,Hematocrit,Mean,41,%,SD,8,NA,NA,NA,NA
15930210,NA,Epinephrine,SCVO2,Mean,72,%,SD,12,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Normal at Initial,Frequency,8,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Grade 1 or 2 IVH at Initial,Frequency,5,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Moderate/Severe PVE at Initial,Frequency,6,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound Normal at Initial,Frequency,13,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound Grade 1 or 2 IVH at Initial,Frequency,4,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound Moderate/Severe PVE at Initial,Frequency,4,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Normal at Final,Frequency,7,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Grade 1  at Finalor 2 IVH,Frequency,6,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Grade 3 IVH at Final,Frequency,3,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound PVHI at Final,Frequency,1,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound PVE at Final,Frequency,5,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Dopamine,Cerebral Ultrasound Posthemorrhagic at Final,Frequency,3,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound Normal at Final,Frequency,11,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound Grade 1  at Finalor 2 IVH,Frequency,6,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound PVE at Final,Frequency,3,Number of patients,NA,NA,NA,NA,NA,NA
15930210,NA,Epinephrine,Cerebral Ultrasound Posthemorrhagic at Final,Frequency,2,Number of patients,NA,NA,NA,NA,NA,NA